HYUNDAI BIOSCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20,150 KRW | -0.49% |
|
+2.23% | -22.80% |
| Sales 2022 | 7.85B 5.72M | Sales 2023 | 9.48B 6.9M | Capitalization | 1,039B 756M |
|---|---|---|---|---|---|
| Net income 2022 | -15.81B -11.51M | Net income 2023 | -14.5B -10.56M | EV / Sales 2022 | 137 x |
| Net cash position 2022 | 12.48B 9.09M | Net cash position 2023 | 6.27B 4.56M | EV / Sales 2023 | 109 x |
| P/E ratio 2022 |
-68.2
x | P/E ratio 2023 |
-71.5
x | Employees | 63 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.08% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.49% | ||
| 1 week | +2.23% | ||
| Current month | -4.05% | ||
| 1 month | -11.82% | ||
| 3 months | -18.42% | ||
| 6 months | -44.11% | ||
| Current year | -22.80% |
1 week
19 970.00
22 600.00
1 month
19 170.0022 600.00
Current year
17 600.0026 350.00
1 year
17 600.0041 200.00
3 years
17 600.0048 600.00
5 years
6 310.0066 300.00
10 years
1 490.0066 300.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Yong-Ju Jeon
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Taek-Sung Kim
BRD | Director/Board Member | 59 | 15-03-26 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Gi Oh
CEO | Chief Executive Officer | 64 | 13-03-28 |
Yeong-Kwon Jeong
BRD | Director/Board Member | 57 | - |
Taek-Sung Kim
BRD | Director/Board Member | 59 | 15-03-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +1.70% | - | |
| 0.00% | 117 M€ | +0.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 20,150 | -0.49% | 148,911 |
| 24-04-23 | 20,250 | +0.25% | 193,970 |
| 24-04-22 | 20,200 | -0.25% | 390,142 |
| 24-04-19 | 20,250 | +0.75% | 1,823,181 |
| 24-04-18 | 20,100 | +1.98% | 140,500 |
End-of-day quote Korea S.E., April 23, 2024
More quotes
HYUNDAI BIOSCIENCE CO., LTD. it is a Korea-based company mainly engaged in the manufacturing and sale of bio cosmetics and hair tonic products. It develops functional daily necessities such as shampoos, mask packs, creams, and tumor-targeted drug. The Company also sells liquid crystal display (LCD) monitors and digital signage display products. The Company distributes its products in domestic market, as well as to the overseas markets, including Europe, America and Japan.
Sector
Personal Products
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -22.80% | 583M | |
| +10.96% | 384B | |
| +5.87% | 120B | |
| +11.49% | 73.05B | |
| -16.27% | 63.71B | |
| +0.76% | 52.82B | |
| -11.15% | 36.63B | |
| +2.03% | 33.15B | |
| +6.24% | 17.05B | |
| +5.82% | 14.89B |
- Stock Market
- Equities
- A048410 Stock
